SAN
RAFAEL, Calif., Jan. 6, 2025
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today
announced that Alexander Hardy,
President and Chief Executive Officer of BioMarin, will present at
the 43rd Annual J.P. Morgan Conference on Monday, January 13, 2024, at 9:00 am PT / 12:00 pm
ET, in San Francisco,
California.
An audio webcast of the presentation will be available live. You
can access the webcast at: https://investors.biomarin.com/. An
archived version of the remarks will also be available through the
Company's website for a limited time following the
conference.
About BioMarin
BioMarin is a global biotechnology
company dedicated to translating the promise of genetic discovery
into medicines that make a profound impact on the life of each
patient. The San Rafael,
California-based company, founded in 1997, has a proven
track record of innovation with eight commercial therapies and a
strong clinical and preclinical pipeline. Using a distinctive
approach to drug discovery and development, BioMarin pursues
treatments that offer new possibilities for patients and families
around the world navigating rare or difficult-to-treat genetic
conditions. To learn more, please visit www.biomarin.com.
|
Contacts:
|
|
|
Investors
|
Media
|
|
Traci McCarty
|
Marni
Kottle
|
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
|
(415)
455-7558
|
(650) 374-2803
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-on-monday-january-13-at-900-am-pt--1200-pm-et-in-san-francisco-ca-302342007.html
SOURCE BioMarin Pharmaceutical Inc.
